Trial intelligence / Profile preview

Klimadynon vs Conjugated Estrogens in Menopause

NCT02184364Phase 3Completed

Sponsor
Boehringer Ingelheim
Start
Nov 1998
Primary completion
Sep 2000
Modality
Small Molecules
01

Overview

A Phase 3 trial of klimadynon in menopause, sponsored by Boehringer Ingelheim. Started Nov 1998; status: completed.

02

Drugs

klimadynon
03

Conditions

menopause

Beyond the preview

Go deeper on NCT02184364.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02184364.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call